Helminthiasis Global Clinical Trials Review, H1, 2015

Helminthiasis Global Clinical Trials Review, H1, 2015


  • Products Id :- GDHC2689CTIDB
  • |
  • Pages: 70
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Helminthiasis Global Clinical Trials Review, H1, 2015

GlobalData's clinical trial report, "Helminthiasis Global Clinical Trials Review, H1, 2015" provides data on the Helminthiasis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Helminthiasis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Helminthiasis . This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each

Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type

Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons To Buy

Understand the dynamics of a particular indication in a condensed manner

Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more

Obtain discontinued trial listing for trials across the globe

Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

Introduction 6

Helminthiasis 6

Report Guidance 6

Clinical Trials by Region 7

Clinical Trials and Average Enrollment by Country 8

Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10

Top Countries Contributing to Clinical Trials in Europe 11

Top Countries Contributing to Clinical Trials in North America 12

Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13

Top Countries Contributing to Clinical Trials in Central and South America 14

Clinical Trials by G7 Countries: Proportion of Helminthiasis to Infectious Disease Clinical Trials 15

Clinical Trials by Phase in G7 Countries 16

Clinical Trials in G7 Countries by Trial Status 17

Clinical Trials by E7 Countries: Proportion of Helminthiasis to Infectious Disease Clinical Trials 18

Clinical Trials by Phase in E7 Countries 19

Clinical Trials in E7 Countries by Trial Status 20

Clinical Trials by Phase 21

In Progress Trials by Phase 22

Clinical Trials by Trial Status 23

Clinical Trials by End Point Status 24

Unaccomplished Trials of Helminthiasis 25

Subjects Recruited Over a Period of Time 26

Clinical Trials by Sponsor Type 27

Prominent Sponsors 28

Top Companies Participating in Helminthiasis Therapeutics Clinical Trials 29

Prominent Drugs 30

Clinical Trial Profiles 31

Clinical Trial Overview of Top Companies 31

Janssen Global Services, LLC 31

Clinical Trial Overview of Janssen Global Services, LLC 31

Deutsche Gesellschaft fur Internationale Zusammenarbeit GmbH 32

Clinical Trial Overview of Deutsche Gesellschaft fur Internationale Zusammenarbeit GmbH 32

Johnson & Johnson 33

Clinical Trial Overview of Johnson & Johnson 33

Icddr,b 34

Clinical Trial Overview of Icddr,b 34

GlaxoSmithKline plc 35

Clinical Trial Overview of GlaxoSmithKline plc 35

E. Merck KG 36

Clinical Trial Overview of E. Merck KG 36

Clinical Trial Overview of Top Institutes / Government 37

Swiss Tropical and Public Health Institute 37

Clinical Trial Overview of Swiss Tropical and Public Health Institute 37

DBL-Centre for Health Research and Development 38

Clinical Trial Overview of DBL-Centre for Health Research and Development 38

London School of Hygiene & Tropical Medicine 39

Clinical Trial Overview of London School of Hygiene & Tropical Medicine 39

Swiss National Science Foundation 40

Clinical Trial Overview of Swiss National Science Foundation 40

The German Society for International Cooperation 41

Clinical Trial Overview of The German Society for International Cooperation 41

University of Kelaniya 42

Clinical Trial Overview of University of Kelaniya 42

Centre de Recherche Medicales de Lambarene 43

Clinical Trial Overview of Centre de Recherche Medicales de Lambarene 43

Hopital Albert Schweitzer Haiti 44

Clinical Trial Overview of Hopital Albert Schweitzer Haiti 44

Ivo de Carneri Foundation 45

Clinical Trial Overview of Ivo de Carneri Foundation 45

Navrongo Health Research Centre 46

Clinical Trial Overview of Navrongo Health Research Centre 46

Five Key Clinical Profiles 47

Appendix 68

Abbreviations 68

Definitions 68

Research Methodology 69

Secondary Research 69

About GlobalData 70

Contact Us 70

Disclaimer 70

Source 70

List of Figures

Helminthiasis Therapeutics, Global, Clinical Trials by Region (%), 2015* 7

Helminthiasis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8

Helminthiasis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9

Helminthiasis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015* 10

Helminthiasis Therapeutics Clinical Trials, Europe, Top Countries (%), 2015* 11

Helminthiasis Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2015* 13

Helminthiasis Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2015* 14

Proportion of Helminthiasis to Infectious Disease Clinical Trials, G7 Countries (%), 2015* 15

Helminthiasis Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16

Helminthiasis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17

Proportion of Helminthiasis to Infectious Disease Clinical Trials, E7 Countries (%), 2015* 18

Helminthiasis Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19

Helminthiasis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20

Helminthiasis Therapeutics, Global, Clinical Trials by Phase (%), 2015* 21

Helminthiasis Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 22

Helminthiasis Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23

Helminthiasis Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24

Helminthiasis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 26

Helminthiasis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 27

Helminthiasis Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 28

Helminthiasis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 29

Helminthiasis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 30

GlobalData Methodology 69

List of Tables

Helminthiasis Therapeutics, Global, Clinical Trials by Region, 2015* 7

Helminthiasis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8

Helminthiasis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9

Helminthiasis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015* 10

Helminthiasis Therapeutics Clinical Trials, Europe, Top Countries, 2015* 11

Helminthiasis Therapeutics Clinical Trials, North America, Top Countries, 2015* 12

Helminthiasis Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2015* 13

Helminthiasis Therapeutics Clinical Trials, Central and South America, Top Countries, 2015* 14

Proportion of Helminthiasis to Infectious Disease Clinical Trials, G7 Countries (%), 2015* 15

Helminthiasis Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16

Helminthiasis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17

Proportion of Helminthiasis to Infectious Disease Clinical Trials, E7 Countries (%), 2015* 18

Helminthiasis Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19

Helminthiasis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20

Helminthiasis Therapeutics, Global, Clinical Trials by Phase, 2015* 21

Helminthiasis Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 22

Helminthiasis Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23

Helminthiasis Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24

Helminthiasis Therapeutics, Global, Terminated Clinical Trials, 2015* 25

Helminthiasis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 26

Helminthiasis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 27

Helminthiasis Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 28

Helminthiasis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 29

Helminthiasis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 30

Helminthiasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Janssen Global Services, LLC, 2015* 31

Helminthiasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Deutsche Gesellschaft fur Internationale Zusammenarbeit GmbH, 2015* 32

Helminthiasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson & Johnson, 2015* 33

Helminthiasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Icddr,b, 2015* 34

Helminthiasis Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2015* 35

Helminthiasis Therapeutics Clinical Trials Market, Global, Clinical Trials by E. Merck KG, 2015* 36

Helminthiasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Swiss Tropical and Public Health Institute, 2015* 37

Helminthiasis Therapeutics Clinical Trials Market, Global, Clinical Trials by DBL-Centre for Health Research and Development, 2015* 38

Helminthiasis Therapeutics Clinical Trials Market, Global, Clinical Trials by London School of Hygiene & Tropical Medicine, 2015* 39

Helminthiasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Swiss National Science Foundation, 2015* 40

Helminthiasis Therapeutics Clinical Trials Market, Global, Clinical Trials by The German Society for International Cooperation, 2015* 41

Helminthiasis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Kelaniya, 2015* 42

Helminthiasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Centre de Recherche Medicales de Lambarene, 2015* 43

Helminthiasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Hopital Albert Schweitzer Haiti, 2015* 44

Helminthiasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Ivo de Carneri Foundation, 2015* 45

Helminthiasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Navrongo Health Research Centre, 2015* 46

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Janssen Global Services, LLC

Deutsche Gesellschaft fur Internationale Zusammenarbeit GmbH

Johnson & Johnson

Icddr,b

GlaxoSmithKline plc

E. Merck KG

Helminthiasis Clinical Trials, Trial Designs, Subjects Recruited, Unaccomplished Trials of Helminthiasis , Pfizer, AstraZeneca, Novartis, GlaxoSmithKline, Sanofi, Eli Lilly and Company, Johnson & Johnson, Merck & Co., Inc, Bristol-Myers Squibb Company, Abbott Laboratories, Hoffmann-La Roche Ltd., Celgene Corporation, Daiichi Sankyo Company, Ltd., Bayer AG, Eisai Inc., GE Healthcare, Biogen Idec Inc., Copharos Inc., Wyeth Pharmaceuticals Inc., National Cancer Center, The University of Texas, M.D. Andersons, Vanderbilt Medical Center, Memorial Sloan Kettering Cancer Center, Cancer Research UK, North Central Cancer Group, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Fred Hutchinson Cancer Research Center, European Organization for Research and Treatment of Cancer, Dana-Farber Cancer Institute, The Cancer and Leukemia Group B, Columbia University, UCLA's Jonsson Comprehensive Cancer Center, Case Comprehensive Cancer Center, Mayo Clinic, Duke University, Ohio State University, National Cancer Center, University of Pennsylvania.

select a license

Single User License
USD 2500 INR 160875
Site License
USD 5000 INR 321750
Corporate User License
USD 7500 INR 482625

NEWSLETTER BY CATEGORY




Testimonials

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies....

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ...

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!...



Related Products in vertical
Ken Research Pvt. Ltd. Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

query [@] kenresearch.com